Friedemann Zengerling

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

Klaus‐Peter Dieckmann, Arlo Radtke, Lajos Géczi et al. · Journal of Clinical Oncology · 2019 · 330 citations · Full text

Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial

Sumanta K. Pal, Laurence Albigès, Piotr Tomczak et al. · The Lancet · 2023 · 173 citations · Full text

Urology, Genitourinary Cancer, Medicine +7

Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract

Cora N. Sternberg, Yohann Loriot, Nicholas D. James et al. · European Urology · 2019 · 132 citations · Full text

<i>NECTIN4</i> Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz et al. · Journal of Clinical Oncology · 2024 · 95 citations · Full text

Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial

Alexandros Papachristofilou, Jens Bedke, Stefanie Hayoz et al. · The Lancet Oncology · 2022 · 58 citations

Surgical Oncology, Single-dose Carboplatin, Radiation Therapy +8